Analysis of China's Health Industry in 2019

Health Industry refers to a series of health products production and operation, service provision and information dissemination related to maintaining health, restoring health and promoting health. The second is the pharmaceutical industry, which mainly produces and sells medicines, medical devices and medical consumables; the third is the health product industry, which mainly produces and sells health food and health products; the fourth is the health management service industry, which mainly includes health testing and evaluation, consultation service, conditioning and rehabilitation, and guarantee and promotion; and the fifth is the health pension industry, which mainly focuses on the pension market. At the present stage, the major health industries in China are mainly pharmaceutical industry and health care industry, with the market share reaching 50.05% and 33.04% respectively, while the health management service industry has the smallest proportion, only 2.71%.

Although our country With the progress of urbanization and the arrival of aging, people's demand for big health will continue to rise, and the potential market scale will become larger with the demand. However, the current consumer groups are still limited to the elderly and the sick, which requires us to further explore the health market. On the other hand, consumers do not know enough about the industry, and even many people do not understand the industry. They believe that the industry is selling drugs and medical equipment. But in fact, the scope of the health industry is very wide, in addition to pharmaceutical companies, but also those health care products, health food, and even foot washing and foot therapy industries are within the scope of the health industry. At present, China's big health industry is in the initial stage of development. The big health industry chain is relatively dispersed in all aspects, and the corresponding distribution of resources is relatively dispersed. This means that various links must be effectively linked through a large number of resource integration. At present, the market competitiveness is changing from industrial operation advantage to capital operation advantage. It is necessary to find effective ways to combine capital, resources, technology and channels for the development of large and healthy industries.

In addition, the business model of China's big health industry is relatively single and backward, and the backward business model will inevitably become a shackle restricting the development of the big health industry. Consumers are the foundation for the development of large healthy industries, because the demand of consumers determines the capacity of the market. After all, big health belongs to emerging industries, and the market needs a gradual process of adaptation. Most health manufacturers are small in scale, lack of systematic integration of competitive products, core technologies, health service communication paths, and can not provide complete health solutions and successful business models to enable consumers to truly sustain their health. Therefore, the development of industry must break through an innovative business model of "design + promotion of products + technology + service + information". At the same time, the traditional health industry also needs to think about how to upgrade and replace industries and products. Compared with the advanced medical and pharmaceutical level in the world, there is still a big gap in innovation research and development at home and abroad. Throughout China's large health industry, the problem of low-level duplication of production is very serious, especially the lack of R&D and technological innovation. Weak technological foundation, insufficient personalized services, frequent copying in health industry and lack of high-tech hinder the development of large health industry. And the big health industry involves many related technologies in the sub-domain, such as the application of artificial intelligence in the field of health care, the layout of big data in the field of health care, the application of modern pharmaceutical technology in the field of big health, and so on. Each sub-area has its own technical requirements, and the degree of integration of these technologies with the field of health care will directly determine the quality of the development of China's large health industry. Therefore, in the deployment of large-scale health industry, we should carry out comprehensive technology research and development in different sub-areas, and not only actively introduce more developed countries.